Gemcitabine/Docetaxel Treats Nonmuscle-Invasive Bladder Cancer
FRIDAY, Aug. 19, 2022 (HealthDay News) — Gemcitabine plus docetaxel (Gem/Doce) may be an alternative for the treatment of high-risk non-muscle-invasive bladder cancer (NMIBC), according to a study published in the September issue of The Journal of Ur…
Learn MoreAsí bajará la Ley de Reducción de la Inflación el costo de la atención de la salud
MIÉRCOLES, 17 de agosto de 2022 (HealthDay News) — El Presidente Joe Biden firmó el martes la Ley de Reducción de la Inflación (Inflation Reduction Act), lo que la convierte en la legislación sobre atención de la salud más significativa que se ha apr…
Learn MoreIvermectin, Luvox Fail as COVID-19 Treatment
THURSDAY, Aug. 18, 2022 (HealthDay News) — Two drugs touted as potential COVID-19 treatments, ivermectin and fluvoxamine, don’t do a thing to improve patients’ oxygen levels and keep them out of the hospital or the morgue, a new clinical trial has sh…
Learn MoreTicagrelor DAPT Linked to Lower Risk for Vein Graft Failure in CABG
WEDNESDAY, Aug. 17, 2022 (HealthDay News) — Ticagrelor dual antiplatelet therapy (DAPT) is associated with a reduced risk for saphenous vein graft failure compared with aspirin among patients undergoing coronary artery bypass graft surgery, according…
Learn MoreHere’s How the Inflation Reduction Act Will Lower the Cost of Health Care
WEDNESDAY, Aug. 17, 2022 (HealthDay News) — President Joe Biden on Tuesday signed the Inflation Reduction Act into law, making it the most significant health care legislation enacted in more than a decade. How will it affect health care?Millions of A…
Learn MoreDupilumab Studied in Patients Hospitalized for COVID-19
TUESDAY, Aug. 16, 2022 (HealthDay News) — Early research suggests that dupilumab, a monoclonal antibody used to treat asthma and eczema, may benefit patients hospitalized with moderate-to-severe COVID-19, according to a study published in the Augus…
Learn MoreUna nueva legislación federal podría reducir los costos de los medicamentos
VIERNES, 12 de agosto de 2022 (HealthDay News) — Se anticipa que la Ley de la Reducción de la Inflación (Inflation Reduction Act) reduzca los gastos de desembolso por los medicamentos de muchos adultos mayores de EE. UU., pero la mayoría de sus benef…
Learn MoreNerve Block Plus Lidocaine Clears Psoriasis in Small Study
MONDAY, Aug. 15, 2022 (HealthDay News) — Spinal injections of a common anesthetic may help clear the inflammatory skin condition psoriasis, a small pilot study suggests.The study involved four patients with severe psoriasis, and researchers are descr…
Learn MoreMepolizumab Cuts Exacerbations in Children With Severe Asthma
MONDAY, Aug. 15, 2022 (HealthDay News) — Asthma exacerbations are reduced for children and adolescents with exacerbation-prone eosinophilic asthma who are living in socioeconomically disadvantaged urban neighborhoods and receive mepolizumab therapy…
Learn MoreHow Will New Federal Legislation Cut Drug Costs?
FRIDAY, Aug. 12, 2022 (HealthDay News) — The Inflation Reduction Act is expected to bring out-of-pocket drug costs down for many U.S. seniors, but most of its benefits are not immediate.
Under the law, Medicare will now be allowed to negotiate th…
Learn More